University of Chicago: Obesity trials
The registry lists 13 Obesity studies with University of Chicago as lead sponsor. 1 are open to participants now and 1 have results posted.
Early Phase 1 1Phase 3 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial FibrillationRecruitingNCT06499857Phase 3
- Sleep Extension or Regularity to Reduce Diabetes RiskCompletedNCT06128265Not applicableResults posted
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesSuspendedNCT06171152Early Phase 1
- Virtual Diabetes Group Visits Across Health SystemsActive, not recruitingNCT06094491Not applicable
- Localized Body Cooling Technology on Sleep and Metabolism in African, American With Overweight and ObesityCompletedNCT05849181Not applicable
- The Impact of Bariatric Surgery on Adipocyte MetabolismCompletedNCT04242524Not applicable
- Technology-Supported Treatment of Sleep Apnea in PrediabetesCompletedNCT04225507Not applicable
- Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)CompletedNCT04090840Not applicable
- Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity RiskWithdrawnNCT03000803Not applicable
- Pathways Linking Reduced Sleep Duration and Quality to Obesity RiskCompletedNCT00915707Not applicable
- Pharmacokinetics of Implanon in Obese WomenCompletedNCT00724438
- REACH-OUT: Chicago Children's Diabetes Prevention ProgramCompletedNCT00723853Not applicable
- Childhood Obesity: Variations in ManagementCompletedNCT00160914